SCHEMBL19051933

SCHEMBL19051933

c1ccc2c(c1)Oc1ccccc1C2=C1c2ccccc2Oc2cnccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
STK17B O94768 2/20 0.44
MAOB P27338 3/20 0.44
MAOA P21397 2/20 0.44
SETD7 Q8WTS6 1/20 0.40
KDM4E B2RXH2 4/20 0.38
MAPK1 P28482 2/20 0.38
ATM Q13315 1/20 0.38
HRH4 Q9H3N8 1/20 0.35
TNF P01375 1/20 0.34
ALDH1A1 P00352 3/20 0.33
ACHE P22303 2/20 0.33
HPGD P15428 2/20 0.33
CYP19A1 P11511 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
IKBKB O14920 1/20 0.33
AURKA O14965 1/20 0.33
CHUK O15111 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17115222 1.00 CYP1A2 (0.44) CYP1A2CYP2D6STK17BMAOBMAOA
SCHEMBL17115226 1.00 CYP1A2 (0.44) CYP1A2CYP2D6STK17BMAOBMAOA
SCHEMBL19051925 0.83 MAOA (0.36) CYP1A2CYP2D6STK17BMAOBMAOA
SCHEMBL19024329 0.83 MAOA (0.36) CYP1A2CYP2D6STK17BMAOBMAOA
SCHEMBL302174 0.80 MAPK1 (0.52) CYP1A2CYP2D6STK17BMAOBMAOA
SCHEMBL29406907 0.80 MAPK1 (0.52) CYP1A2CYP2D6STK17BMAOBMAOA
SCHEMBL11544354 0.76 MAOA (0.39) CYP1A2STK17BMAOBMAOAKDM4E
SCHEMBL1365275 0.74 CYP1A2 (0.43) CYP1A2CYP2D6STK17BMAOBMAOA
SCHEMBL14380259 0.73 MAOA (0.65) CYP1A2CYP2D6MAOBMAOAKDM4E
SCHEMBL28512593 0.73 MAOA (0.65) CYP1A2CYP2D6MAOBMAOAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170183356-A1 New Imaging Agents and Methods of Identifying Same THR TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2017-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170183356-A1 New Imaging Agents and Methods of Identifying Same DDX3X, DDX21, DAXX CYP1A2 4117/4885CYP2D6 4490/4885STK17B 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.